News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Policy
Johnson & Johnson Unit Needs More Inspection After Lapses Says FDA
May 26, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Reuters -- The U.S. Food and Drug Administration is calling for further inspection and an outside audit of a Johnson & Johnson unit following manufacturing lapses.
Twitter
LinkedIn
Facebook
Email
Print
Regulatory
Johnson & Johnson Family of Companies
MORE ON THIS TOPIC
Huntington’s disease
UniQure crashes as Huntington’s gene therapy shows less slowing of disease at 4 years
September 29, 2026
·
4 min read
·
Heather McKenzie
Approvals
AbbVie wins FDA approval for Parkinson’s drug from $8.7B Cerevel takeover
September 28, 2026
·
2 min read
·
Tristan Manalac
Lung cancer
Merck, Daiichi Sankyo retract accelerated approval request for lung cancer ADC
September 28, 2026
·
2 min read
·
Tristan Manalac
IN PARTNERSHIP WITH LONGEVITY MEDICAL INSTITUTE
Regenerative medicine needs more than stem cells
September 28, 2026
·
4 min read
·
Jennifer C. Smith-Parker